March 17 (Reuters) - Caladrius Biosciences Inc
* Caladrius Biosciences announces 2016 fourth quarter and full year financial results
* Q4 revenue rose 35 percent to $10.2 million
* Q4 loss per share $0.73
* As of December 31, 2016, Caladrius had cash and cash equivalents of $14.7 million Source text for Eikon: Further company coverage: